Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
CRBP
↓ PDF (Pro)Corbus Pharmaceuticals Holdings Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$10.49
-0.33%today
MKT CAP
$193M
+4.9% · 1Y
Earnings History
-29.6%
-8.4%
-11.3%
+20.7%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$10.49
Low
$28.00
Analyst Mean
$41.67
High
$57.00
9 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-0.4x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-54.2%
Debt / Equity1.11x
Free Cash Flow$-37,728,752
Insider Ownership0.6%
Institutional Ownership75.5%
Short % of Float8.79%
Days to Cover6.5d
1 Week+5.9%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| SMETHURST DOMINIC | Officer | Sale | 6,097 | $8.30 | $0.05M | 2026-03-02 |
| HODGSON IAN | Chief Operating Officer | Sale | 847 | $7.38 | $0.01M | 2026-02-17 |
| MORAN SEAN F | Chief Financial Officer | Sale | 4,701 | $7.78 | $0.04M | 2026-02-13 |
| COHEN YUVAL | Chief Executive Officer | Sale | 13,871 | $7.78 | $0.11M | 2026-02-13 |
| SMETHURST DOMINIC | Officer | Sale | 3,285 | $8.09 | $0.03M | 2026-02-03 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | institution | 13.22% | $0.03B | -1.26% | 2025-12-31 |
| Orbimed Advisors LLC. | institution | 9.01% | $0.02B | +36.25% | 2025-12-31 |
| Aberdeen Group plc | institution | 7.45% | $0.01B | +0.00% | 2026-03-31 |
| Octagon Capital Advisors LP | institution | 5.38% | $0.01B | -14.35% | 2025-12-31 |
| Vanguard Group Inc | institution | 4.85% | $0.01B | +40.42% | 2025-12-31 |
| Citadel Advisors Llc | institution | 4.75% | $0.01B | +100.00% | 2025-12-31 |
| abrdn Healthcare Investors | fund | 4.39% | $0.01B | +100.00% | 2025-12-31 |
| Prosight Management, Lp | institution | 3.86% | $0.01B | +99.15% | 2025-12-31 |
| abrdn Life Sciences Investors | fund | 3.07% | $0.01B | +188.86% | 2025-12-31 |
| Armistice Capital, LLC | institution | 3.02% | $0.01B | +179.17% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 3.01% | $0.01B | +41.96% | 2025-12-31 |
| Stonepine Capital Management, LLC | institution | 2.20% | $0.00B | +100.00% | 2025-12-31 |
| Renaissance Technologies, LLC | institution | 2.00% | $0.00B | +230.50% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 1.01% | $0.00B | +35.99% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.48% | $0.00B | +0.55% | 2026-02-28 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.23% | $0.00B | +43.35% | 2026-03-31 |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Portfolio | fund | 0.16% | $0.00B | +395.13% | 2026-01-31 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | fund | 0.15% | $0.00B | +0.00% | 2026-03-31 |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | fund | 0.14% | $0.00B | +1823.94% | 2026-01-31 |
| Vanguard Explorer Fund | fund | 0.14% | $0.00B | +0.00% | 2026-01-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for CRBP.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.